August 7, 2022 Comments Off on New patent expiration for COVIS drug TUDORZA PRESSAIR Posted in: Uncategorized
Annual Drug Patent Expirations for TUDORZA+PRESSAIR Tudorza Pressair is a drug marketed by Covis and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent expiration for COVIS drug TUDORZA PRESSAIR appea…
August 7, 2022 Comments Off on New patent expiration for COVIS drug DUAKLIR PRESSAIR Posted in: Uncategorized
Annual Drug Patent Expirations for DUAKLIR+PRESSAIR Duaklir Pressair is a drug marketed by Covis and is included in one NDA. There are five patents protecting this drug. This drug has…
The post New patent expiration for COVIS drug DUAKLIR PRESSAIR appe…
